Cheng-Chin Kuo

1.4k total citations
45 papers, 1.1k citations indexed

About

Cheng-Chin Kuo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Cheng-Chin Kuo has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Cheng-Chin Kuo's work include Immune Response and Inflammation (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Cell Adhesion Molecules Research (6 papers). Cheng-Chin Kuo is often cited by papers focused on Immune Response and Inflammation (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Cell Adhesion Molecules Research (6 papers). Cheng-Chin Kuo collaborates with scholars based in Taiwan, United States and Iran. Cheng-Chin Kuo's co-authors include Jing-Yiing Wu, Kenneth K. Wu, Guan-Lin Lee, Shaw‐Fang Yet, Shu‐Mei Liang, Chi‐Ming Liang, Yi‐Fu Wang, Yu‐Juei Hsu, Liang‐Tung Yang and Pei‐Hsuan Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Applied Physics Letters.

In The Last Decade

Cheng-Chin Kuo

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Cheng-Chin Kuo

Since Specialization

Citations

This map shows the geographic impact of Cheng-Chin Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Chin Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Chin Kuo more than expected).

Fields of papers citing papers by Cheng-Chin Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Chin Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Chin Kuo. The network helps show where Cheng-Chin Kuo may publish in the future.

Co-authorship network of co-authors of Cheng-Chin Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Chin Kuo. A scholar is included among the top collaborators of Cheng-Chin Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Chin Kuo. Cheng-Chin Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5-Methoxytryptophan Protects against Toll-Like Receptor 2-Mediated Renal Tissue Inflammation and Fibrosis in a Murine Unilateral Ureteral Obstruction Model 2025 ·Journal of Innate Immunity ·Jing-Yiing Wu, Guan-Lin Lee, (unknown), Cheng-Chin Kuo, Yu‐Juei Hsu, Kenneth K. Wu	1
2	Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis 2024 ·Biomolecules ·(unknown), Ping‐Hsun Wu, (unknown), Po‐Yu Liu, Cheng-Chin Kuo, Yun‐Shiuan Chuang, (unknown), Mei‐Chuan Kuo, Yi‐Wen Chiu, Yi‐Ting Lin	6
3	The effects of acetylated cordycepin derivatives on promoting vascular angiogenesis and attenuating myocardial ischemic injury 2024 ·Heliyon ·Tzu-Ching Chang, (unknown), Yi-Jhu Lu, Shu-Man Liang, Jia‐Yi Wei, (unknown), Song‐Kun Shyue, Cheng-Chin Kuo, Jun‐Yang Liou	0
4	Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan 2022 ·Computational and Structural Biotechnology Journal ·(unknown), Kuang-Mao Chiang, (unknown), Chia‐Min Chung, Chi-Jen Lo, Ming‐Shi Shiao, Mei‐Ling Cheng, Cheng-Chin Kuo, Hsin‐Chou Yang, Wen‐Harn Pan	3
5	Cancer-derived extracellular succinate: a driver of cancer metastasis 2022 ·Journal of Biomedical Science ·Cheng-Chin Kuo, Jing-Yiing Wu, Kenneth K. Wu	60
6	Cordycepin Suppresses Endothelial Cell Proliferation, Migration, Angiogenesis, and Tumor Growth by Regulating Focal Adhesion Kinase and p53 2019 ·Cancers ·(unknown), Shu-Man Liang, (unknown), Yi‐Ju Wu, Yi-Jhu Lu, Yee‐Jee Jan, Bor‐Sheng Ko, Yung‐Jen Chuang, Song‐Kun Shyue, Cheng-Chin Kuo, Jun‐Yang Liou	24
7	Vanadium Derivative Exposure Promotes Functional Alterations of VSMCs and Consequent Atherosclerosis via ROS/p38/NF-κB-Mediated IL-6 Production 2019 ·International Journal of Molecular Sciences ·Chang-Ching Yeh, Jing-Yiing Wu, Guan-Lin Lee, (unknown), Pinpin Lin, Cheng-Chin Kuo	28
8	Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation 2016 ·Circulation Research ·Yi‐Fu Wang, Yu‐Juei Hsu, (unknown), Guan-Lin Lee, Ya‐Sung Yang, Jing-Yiing Wu, Shaw‐Fang Yet, Kenneth K. Wu, Cheng-Chin Kuo	69
9	Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation 2016 ·PLoS ONE ·(unknown), Yi‐Fu Wang, (unknown), Cheng-Chin Kuo, Kenneth K. Wu	32
10	sn-1,2-diacylglycerols protect against lethal endotoxemia by controlling systemic inflammation 2016 ·Immunobiology ·Yi‐Fu Wang, Guan-Lin Lee, Yuhua Huang, Cheng-Chin Kuo	14
11	TLR4 induces CREB-mediated IL-6 production via upregulation of F-spondin to promote vascular smooth muscle cell migration 2016 ·Biochemical and Biophysical Research Communications ·Guan-Lin Lee, Jing-Yiing Wu, Chang-Ching Yeh, Cheng-Chin Kuo	16
12	N-terminal functional domain of Gasdermin A3 regulates mitochondrial homeostasis via mitochondrial targeting 2015 ·Journal of Biomedical Science ·Pei‐Hsuan Lin, (unknown), Cheng-Chin Kuo, Liang‐Tung Yang	84
13	Quiescent and Proliferative Fibroblasts Exhibit Differential p300 HAT Activation through Control of 5-Methoxytryptophan Production 2014 ·PLoS ONE ·(unknown), (unknown), (unknown), Tzu-Ching Chang, Cheng-Chin Kuo, Kenneth K. Wu	14
14	Lobe-Specific Calcium Binding in Calmodulin Regulates Endothelial Nitric Oxide Synthase Activation 2012 ·PLoS ONE ·(unknown), Cheng-Chin Kuo, Shaw‐Fang Yet, Jun‐Yang Liou, Kenneth K. Wu, Peifeng Chen	7
15	Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells 2011 ·Molecular BioSystems ·Yiwen Chen, (unknown), Szu‐Ting Lin, Jimin Li, (unknown), Jingyi Chen, Jing-Yiing Wu, Cheng-Chin Kuo, Chieh‐Lin Wu, (unknown), (unknown), (unknown), (unknown), (unknown), Ping‐Chiang Lyu, Hsiu‐Chuan Chou, Hong‐Lin Chan	37
16	Pivotal Role of ADP-ribosylation Factor 6 in Toll-like Receptor 9-mediated Immune Signaling 2011 ·Journal of Biological Chemistry ·Jing-Yiing Wu, Cheng-Chin Kuo	25
17	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B 2009 ·Life Sciences ·Bor‐Sheng Ko, Tzu-Ching Chang, Chien‐Hung Chen, (unknown), Cheng-Chin Kuo, Chiun Hsu, Ying‐Chun Shen, Tang‐Long Shen, Vita Golubovskaya, Chung-Che Chang, Song‐Kun Shyue, Jun‐Yang Liou	31
18	Effects of CpG-B ODN on the protein expression profile of swine PBMC 2007 ·Veterinary Research ·(unknown), Cheng-Chin Kuo, Chi‐Ming Liang, Chi‐Min Chen, Shu‐Mei Liang	3
19	CpG-B Oligodeoxynucleotide Promotes Cell Survival via Up-regulation of Hsp70 to Increase Bcl-xL and to Decrease Apoptosis-inducing Factor Translocation 2006 ·Journal of Biological Chemistry ·Cheng-Chin Kuo, Shu‐Mei Liang, Chi‐Ming Liang	33
20	Class I and III Phosphatidylinositol 3′-Kinase Play Distinct Roles in TLR Signaling Pathway 2006 ·The Journal of Immunology ·Cheng-Chin Kuo, Wenting Lin, Chi‐Ming Liang, Shu‐Mei Liang	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact